The primary role of the WAHTN Management Committee is to coordinate platform programs across WAHTN and receive input from the themes and cross cutting initiatives of WAHTN

Chair: Professor Gary Geelhoed

Associates:

  • Brightwater: Mr John Bearley
  • Centre for Entrepreneurial Research and Innovation: Dr Carolyn Williams
  • Genetic and Rare Disease Network: Ms Amanda Samanek
  • Linear Clinical Research: Dr Michael Winlo